Clinical trial

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

NCT00527735

Study summary

ClinicalTrials.gov

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Ipilimumab Normalized identity: ipilimumab View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Carboplatin Normalized identity: carboplatin View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-02-01

PhasePHASE2

Conditions

Lung Cancerverified · MONDO: lung cancer

Small Cell Lung Cancerverified · MONDO: small cell lung carcinoma

Carcinoma, Non-Small-Cell Lungcandidate · MONDO: non-small cell lung carcinoma

Interventions

IpilimumabDRUG · verified · RxNorm: ipilimumab

PlaceboDRUG

PaclitaxelDRUG · verified · RxNorm: paclitaxel

CarboplatinDRUG · verified · RxNorm: carboplatin

Sponsors & collaborators

Bristol-Myers Squibblead sponsor

Mapped research locations

Saint PetersburgRussia5 MoscowRussia3 New YorkNew York, United States1 BostonMassachusetts, United States1 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 AtlantaGeorgia, United States1 BirminghamAlabama, United States1 San DiegoCalifornia, United States1 ColumbusOhio, United States1 MinneapolisMinnesota, United States1 OrlandoFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00527735 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.